Oxazolidone derivative

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/04 (2006.01) A61K 31/41 (2006.01) A61K 31/445 (2006.01) A61K 31/535 (2006.01) C07D 263/57 (2006.01) C07D 413/04 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2116337

ABSTRACT An oxazolidone derivative represented by the following general formula (I) or a pharmacologically acceptable salt thereof which has a monoamine oxidase inhibition effect: Image (I) {wherein A and B each represents a nitrogen atom, a sulfur atom or an oxygen atom, with the proviso that at least one of A and B must be a nitrogen atom, R1 represents a group such as a group represented by the formula: Image (in which n and m each represents 0 or an integer of 1 to 4, and R3 and R4 each represents a hydrogen atom, a hydroxyl group, a lower alkyl group, etc.), a group represented by the formula: Image (in which p and q each represents 0 or an integer of 1 to 4 and X represents an oxygen atom, sulfur atom, - 74 - etc.) and a group represented by the formula: Image (in which R5 and R6 each represents a hydrogen atom or a group such as a cyanoalkyl group, or R5 and R6 may form a ring together with the nitrogen atom to which they are bonded), R2 represents a hydrogen atom or a lower alkyl group, and the bond represented by Image represents a single or double bond}. - 75 -

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oxazolidone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxazolidone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidone derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1967362

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.